Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR1 | P21453 | 4/20 | 0.57 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.49 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.49 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.46 |
| ▸ | MRGPRX4 | Q96LA9 | 6/20 | 0.44 |
| ▸ | RXRA | P19793 | 2/20 | 0.44 |
| ▸ | RXRB | P28702 | 2/20 | 0.44 |
| ▸ | RXRG | P48443 | 2/20 | 0.44 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.40 |
| ▸ | MAOB | P27338 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL77508 | 0.99 | S1PR1 (0.56) | S1PR1CYP4F2CYP4A11S1PR3MRGPRX4 | |
| SCHEMBL86784 | 0.93 | S1PR1 (0.56) | S1PR1CYP4F2CYP4A11S1PR3MRGPRX4 | |
| Hydrochloric Acid SCHEMBL81483 | 0.92 | S1PR1 (0.55) | S1PR1CYP4F2CYP4A11S1PR3MRGPRX4 | |
| SCHEMBL82001 | 0.91 | S1PR1 (0.48) | S1PR1CYP4F2CYP4A11S1PR3MRGPRX4 | |
| SCHEMBL82000 | 0.90 | S1PR1 (0.48) | S1PR1CYP4F2CYP4A11S1PR3MRGPRX4 | |
| SCHEMBL86430 | 0.89 | S1PR1 (0.62) | S1PR1S1PR3 | |
| SCHEMBL93005 | 0.85 | S1PR1 (0.62) | S1PR1MRGPRX4RXRARXRBRXRG | |
| SCHEMBL81315 | 0.84 | S1PR1 (0.47) | S1PR1S1PR3MRGPRX4RXRARXRB | |
| SCHEMBL81314 | 0.83 | S1PR1 (0.46) | S1PR1S1PR3MRGPRX4RXRARXRB | |
| SCHEMBL86569 | 0.83 | S1PR1 (0.59) | S1PR1S1PR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8129361-B2 | Amine compound and pharmaceutical use thereof | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2012-03-06 | — | — | US | disclosed |
| US-20100179216-A1 | AMINE COMPOUND AND PHARMACEUTICAL USE THEREOF | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2010-07-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100179216-A1 | AMINE COMPOUND AND PHARMACEUTICAL USE THEREOF | HLA-B, HLA-A, HLA-C | S1PR1 511/4885CYP4F2 238/4885CYP4A11 41/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.